A. Spooner

Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective

P. Arlett, Heidi Janssen, Rodrigo Postigo, 2014, Pharmaceutical Medicine.

Evaluation of the effectiveness of risk minimization measures

A. Rubino, X. Kurz, P. Arlett, 2012, Pharmacoepidemiology and drug safety.

An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration

O. Corrigan, D. D'Arcy, M. Donnelly, 2011, BMC clinical pharmacology.

Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works

Peter Arlett, Georgy Genov, G. Genov, 2017, Drug Safety.

Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee

G. Rasi, J. Dogné, J. Raine, 2014, Nature Reviews Drug Discovery.

Principles for Good Practice in the Conduct of Non-interventional Studies: The View of Industry Researchers

Valerie D. Lehner, Bartley L. Barefoot, P. Verpillat, 2023, Therapeutic Innovation & Regulatory Science.